Cargando…
Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning
In various clinical studies, Hodgkin’s patients have been treated with anti-CD30 immunotherapeutic agents and have shown promising responses. One of the problems that appeared from these studies is the development of an immune response against the non-human therapeutics, which limits repeated admini...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2000
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363493/ https://www.ncbi.nlm.nih.gov/pubmed/10901379 http://dx.doi.org/10.1054/bjoc.2000.1226 |